These findings suggest that the risk of CHD in patients with NAFLD significantly increases with elevating TG/HDL-C ratios, independent of BMI, age, sex, smoking, HTN, AST, ALT, TC, DM, Scr, FBG, and HR. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.